2008-11-19 11:11:01 - Enzon Pharmaceuticals, Inc. - SWOT Analysis - a new market research report on http://www.companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/Enzon-Pharma ..

Datamonitor´s Enzon Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Enzon Pharmaceuticals (Enzon) is a biopharmaceutical company engaged in the development, manufacturing and commercialization of therapeutics to treat cancer and other life-threatening diseases. The company currently markets Oncaspar, DepoCyt, Abelcet and Adagen. The company primarily operates in the US and Europe. It is headquartered in Bridgewater, New Jersey and employs about 370 people. The company recorded revenues of $185.6 million during the financial year (FY) ended December 2007, a decrease of 0.03% over 2006. The decrease

 

 

was due to lower royalty revenues earned on the sales of PEG-INTRON. The operating profit of the company was $90.5 million during FY2007, as compared to an operating profit of $10.6 million in 2006. The net profit was $83.1 million in FY2007, as compared to a net profit of $21.3 million in 2006.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available